As the $70 billion merger between CVS Health and Aetna Inc. draws near, the combined company will create a industry-changing model for health care that is more personal than ever before, according to Larry Merlo, CVS Health’s president and chief executive officer.
Retail pharmacy advocates applauded the House of Representatives for unanimously passing two bipartisan bills that aim to lower drug costs. The bills — the Patient Right to Know Drug Prices Act and the Know the Lowest Price Act — had originated in the Senate, where each had gained earlier approval.
Rite Aid Corp. has changed its corporate governance and recast its board. The company separated the chairman and chief executive officer functions, with director Bruce Bodaken becoming chairman and John Standley remaining CEO.
On October 27 the Drug Enforcement Agency (DEA) will hold its 14th National Consumer Drug Take-Back Day. The event will be well publicized and will enable the safe and secure disposal of millions of pounds of expired and unneeded prescription medications.
A little over 40 years ago, the first issue of Chain Drug Review appeared.
